Researchers
Discover all researchers in life sciences
Loading researchers...
Shaker A. Mousa
President and CEO at Pharmaceutical Sciences
Angiogenesis And Vegf In Cancer
Cardiology
Cell Adhesion Molecules Research
Platelet Disorders And Treatments
Venous Thromboembolism Diagnosis And Management
31.9K
Citations
82
H-index
0
Patents
100
Publications
0
Grants
$0
Total Funding
AI Research AssistantBeta
Ask questions about Shaker A. Mousa's research, publications, and ongoing work
What are their main research contributions?
Show me their collaboration network
What grants fund their research?
Research Contributions
Pioneering research on the role of angiogenesis in cancer treatment
Authored a significant publication on the role of angiogenesis in cancer treatment, providing insights into potential therapeutic targets and strategies.
Biomedicines (2017)
Development of novel peptide antagonists for GPIIb/IIIa
Identified novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library, contributing to antiplatelet therapy research.
Proteins Structure Function and Bioinformatics (1992)
Research on the use of nanoparticles in cancer therapy
Published a concise review on nanoparticles and cancer therapy, emphasizing the role of dendrimers, which has been highly cited.
International Journal of Nanomedicine (2009)
Investigation of the anti-angiogenic properties of gold and silver nanoparticles
Conducted research on gold and silver nanoparticles conjugated with heparin derivatives, demonstrating their anti-angiogenesis properties.
Nanotechnology (2009)
Studies on the impact of thyroid hormone on angiogenesis
Investigated the role of integrin αVβ3 in thyroid hormone-induced angiogenesis, providing insights into the mechanisms of action.
Endocrinology (2005)
Research on the use of nanoformulated green tea polyphenol EGCG
Demonstrated the efficacy of oral administration of chitosan-based nanoformulated green tea polyphenol EGCG in inhibiting prostate cancer cell growth.
Carcinogenesis (2013)
Contributions to the development of international clinical practice guidelines
Contributed to the development of international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Journal of Thrombosis and Haemostasis (2012)
Research Highlights
Dr. Shaker A. Mousa is a leading researcher in the fields of angiogenesis, cancer therapy, and cardiovascular disease, with significant contributions to nanomedicine and drug discovery. His work has led to advancements in targeted therapies and innovative approaches to disease management.
Research Areas
Angiogenesis And Vegf In CancerCardiologyCell Adhesion Molecules ResearchPlatelet Disorders And TreatmentsVenous Thromboembolism Diagnosis And Management
Similar Researchers You Should Know
Researchers with overlapping expertise and complementary work
Finding similar researchers...